We’re excited to start season 2 of the Novel Targets Podcast with an episode on the Cancer Immunity Cycle!
While in New Orleans for the 2016 annual meeting of the American Association for Cancer Research (AACR), we rented a studio at WWNO New Orleans public radio to talk with Dr Daniel Chen (@DanChenMDPhD) and Dr Ira Mellman.
Dr Chen (pictured left) is an oncologist and an immunologist. He leads the cancer immunotherapy product development group at Genentech and Roche (In August 2018 Dr Chen became Chief Medical Officer of IGM Biosciences). Dr Mellman (pictured right) is Vice President of cancer immunology at Genentech in South San Francisco.